A neurodevelopmental perspective on hallucinations

The Neuroscience of Hallucinations

Volumn , Issue , 2013, Pages 203-230

  David, Christopher N ^a   Rapoport, Judith L ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84940435065     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-4121-2_12     Document Type: Chapter

References (117)

1. Abel, K.M., Wicks, S. et al. (2010). Birth weight, schizophrenia, and adult mental disorder; is risk confined to the smallest babies?Archives of General Psychiatry,67(9), 923-930.
2. Addington, A. M., Gornick, M., Duckworth, J., Sporn, A., Gogtay, N., Bobb, A., et al. (2005). GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Molecular Psychiatry, 10(6),581-588.
3. Arendt, M., Rosenberg, R., Foldager, L., Perto, G., & Munk-Jorgensen, P. (2005). Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: Follow-up study of 535 incident cases. The British Journal of Psychiatry, 187,510-515.
4. Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002). Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study. British Medical Journal,325(7374), 1212-1213.
5. Aug, R. G., & Ables, B. S. (1971). Hallucinations in nonpsychotic children. Child Psychiatry and Human Development,1(3), 152-167.
6. Basavarajappa, B. S., Nixon, R. A., & Arancio, O. (2009). Endocannabinoid system: Emerging role from neurodevelopment to neurodegeneration. Mini Reviews in Medicinal Chemistry,9(4), 448-462.
7. Biederman, J., Petty, C., Faraone, S. V., & Seidman, L. (2004). Phenomenology of childhood psychosis: Findings from a large sample of psychiatrically referred youth. The Journal of Nervous and Mental Disease,192(9), 607-614.
8. Boksa, P. (2009). On the neurobiology of hallucinations. Journal of Psychiatry & Neuroscience, 34(4), 260-262.
9. Braun, C. M., Dumont, M., Duval, J., Hamel-Hebert, I., & Godbout, L. (2003). Brain modules of hallucination: An analysis of multiple patients with brain lesions. Journal of Psychiatry & Neuroscience,28(6), 432-449.
10. Burke, P., DelBeccaro, M., McCauley, E., & Clark, C. (1985). Hallucinations in children. Journal of the American Academy of Child Psychiatry,24(1), 71-75.
11. Calderoni, D., Wudarsky, M., Bhangoo, R., Dell, M. L., Nicolson, R., Hamburger, S. D., et al. (2001). Differentiating childhood-onset schizophrenia from psychotic mood disorders. Journal of the American Academy of Child and Adolescent Psychiatry,40(10), 1190-1196.
12. Cannon, M., Jones, P. B., & Murray, R. M. (2002). Obstetric complications and schizophrenia: Historical and meta-analytic review. The American Journal of Psychiatry,159(7), 1080-1092.
13. Cannon, T. D., van Erp, T. G., Bearden, C. E., Loewy, R., Thompson, P., Toga, A. W., et al. (2003). Early and late neurodevelopmental influences in the prodrome to schizophrenia: Contributions of genes, environment, and their interactions. Schizophrenia Bulletin,29(4), 653-669.
14. Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., et al. (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction. Biological Psychiatry,57(10), 1117-1127.
15. Castner, S. A., & Goldman-Rakic, P. S. (1999). Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys. Neuropsychopharmacology, 20(1), 10-28.
16. Chambers, W. J., Puig-Antich, J., Tabrizi, M. A., & Davies, M. (1982). Psychotic symptoms in prepubertal major depressive disorder. Archives of General Psychiatry,39(8), 921-927.
17. Chummun, H., Tilley, V., & Ibe, J. (2010). 3,4-Methylenedioxyamfetamine (ecstasy) use reduces cognition. The British Journal of Nursing, 19(2), 94-100.
18. Coskun, M., & Zoroglu, S. (2008). Tactile and visual hallucinations in a child with methylphenidate and fluoxetine combination. Journal of Clinical Psychopharmacology,28(6), 723-725.
19. Del Beccaro, M. A., Burke, P., & McCauley, E. (1988). Hallucinations in children: A follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry,27(4), 462-465.
20. Dhossche, D., Ferdinand, R., van der Ende, J., Hofstra, M. B., & Verhulst, F. (2002). Diagnostic outcome of self-reported hallucinations in a community sample of adolescents. Psychological Medicine,32(4), 619-627.
21. Dosenbach, N. U., Nardos, B., Cohen, A. L., Fair, D. A., Power, J. D., Church, J. A., et al. (2010). Prediction of individual brain maturity using fMRI. Science,329(5997), 1358-1361.
22. Edelsohn, G. A., Rabinovich, H., & Portnoy, R. (2003). Hallucinations in nonpsychotic children: Findings from a psychiatric emergency service. Annals of the New York Academy of Sciences, 1008,261-264.
23. Egdell, H. G., & Kolvin, I. (1972). Childhood hallucinations. Journal of Child Psychology and Psychiatry,13(4), 279-287.
24. Feinberg, I. (1983). Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?Journal of Psychiatric Research, 17,319-344.
25. Fine, J., & Finestone, S. C. (1973). Sensory disturbances following ketamine anesthesia: Recurrent hallucinations. Anesthesia and Analgesia,52(3), 428-430.
26. Garralda, M. E. (1982). Hallucinations in psychiatrically disordered children: Preliminary communication. Journal of the Royal Society of Medicine,75(3), 181-184.
27. Garralda, M. E. (1984a). Hallucinations in children with conduct and emotional disorders: I. The clinical phenomena. Psychological Medicine, 14(3), 589-596.
28. Garralda, M. E. (1984b). Hallucinations in children with conduct and emotional disorders: II. The follow-up study. Psychological Medicine,14(3), 597-604.
29. Garralda, M. E. (1984c). Psychotic children with hallucinations. The British Journal of Psychiatry, 145, 74-77.
30. Geddes, J. (1999). Prenatal and perinatal and perinatal risk factors for early onset schizophrenia, affective psychosis, and reactive psychosis. British Medical Journal,318(7181), 426.
31. Giedd, J. N., Jeffries, N. O., Blumenthal, J., Castellanos, F. X., Vaituzis, A. C., Fernandez, T., et al. (1999). Childhood-onset schizophrenia: Progressive brain changes during adolescence. Biological Psychiatry,46(7), 892-898.
32. Gloor, A., Dillier, C., & Gerber, A. (2001). Ketamine for short ambulatory procedures in children: An audit. Paediatric Anaesthesia,11(5), 533-539.
33. Gochman, P. A., Greenstein, D., Sporn, A., Gogtay, N., Keller, B., Shaw, P., et al. (2005). IQ stabilization in childhood-onset schizophrenia. Schizophrenia Research,77(2-3), 271-277.
34. Gogtay, N., Greenstein, D., Lenane, M., Clasen, L., Sharp, W., Gochman, P., et al. (2007). Cortical brain development in nonpsychotic siblings of patients with childhood-onset schizophrenia. Archives of General Psychiatry,64(7), 772-780.
35. Gogtay, N., Sporn, A., Clasen, L. S., Nugent, T. F., III, Greenstein, D., Nicolson, R., et al. (2004). Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses.Archives of General Psychiatry,61(1), 17-22.
36. Green, W. H., Campbell, M., Hardesty, A. S., Grega, D. M., Padron-Gayol, M., Shell, J., et al. (1984). A comparison of schizophrenic and autistic children. Journal of the American Academy of Child Psychiatry,23(4), 399-409.
37. Green, W. H., Padron-Gayol, M., Hardesty, A. S., & Bassiri, M. (1992). Schizophrenia with childhood onset: A phenomenological study of 38 cases. Journal of the American Academy of Child and Adolescent Psychiatry,31(5), 968-976.
38. Greenstein, D., Lerch, J., Shaw, P., Clasen, L., Giedd, J., Gochman, P., et al. (2006). Childhood onset schizophrenia: Cortical brain abnormalities as young adults. Journal of Child Psychology and Psychiatry,47(10), 1003-1012.
39. Gross-Tsur, V., Joseph, A., & Shalev, R. S. (2004). Hallucinations during methylphenidate therapy. Neurology, 63(4), 753-754.
40. Gualtieri, C. T., Adams, A., Shen, C. D., & Loiselle, D. (1982). Minor physical anomalies in alcoholic and schizophrenic adults and hyperactive and autistic children. The American Journal of Psychiatry,139(5), 640-643.
41. Harkany, T., Keimpema, E., Barabas, K., & Mulder, J. (2008). Endocannabinoid functions controlling neuronal specification during brain development. Molecular and Cellular Endocrinology, 286(1-2 Suppl 1), S84-S90.
42. Harris, J. M., Yates, S., Miller, P., Best, J. J., Johnstone, E. C., & Lawrie, S. M. (2004). Gyrification in first-episode schizophrenia: A morphometric study. Biological Psychiatry,55(2), 141-147.
43. Ho, B. C., Andreasen, N. C., Nopoulos, P., Arndt, S., Magnotta, V., & Flaum, M. (2003). Progressive structural brain abnormalities and their relationship to clinical outcome: A longitudinal magnetic resonance imaging study early in schizophrenia. Archives of General Psychiatry,60(6), 585-594.
44. Hollis, C. and Taylor, E. (1997). Schizophrenia: a critique from the developmental psychopathology perspective. Neurodevelopment & Adult Psychopathology. Cambridge: Cambridge University Press.
45. Howes, O. D., & Kapur, S. (2009). The dopamine hypothesis of schizophrenia: Version III—The final common pathway. Schizophrenia Bulletin, 35(3), 549-562.
46. Hultman, C. M., Sparen, P., Takei, N., Murray, R. M., & Cnattingius, S. (1999). Prenatal and perinatal risk factors for schizophrenia, affective psychosis, and reactive psychosis of early onset: Case-control study. British Medical Journal,318(7181), 421-426.
47. Inder, T., Neil, J., Yoder, B., & Rees, S. (2004). Non-human primate models of neonatal brain injury. Seminars in Perinatology,28(6), 396-404.
48. Jacobson, S., Kelleher, I., Harley, M., Murtagh, A., Clarke, M., Blanchard, M., et al. (2010). Structural and functional brain correlates of subclinical psychotic symptoms in 11-13 year old schoolchildren. NeuroImage,49(2), 1875-1885.
49. Jaffe, S. L. (1966). Hallucinations in children at a state hospital. The Psychiatric Quarterly,40(1), 88-95.
50. James, A. C., Javaloyes, A., James, S., & Smith, D. M. (2002). Evidence for non-progressive changes in adolescent-onset schizophrenia: Follow-up magnetic resonance imaging study. The British Journal of Psychiatry, 180,339-344.
51. Javitt, D. C. (2010). Glutamatergic theories of schizophrenia. The Israel Journal of Psychiatry and Related Sciences,47(1), 4-16.
52. Jones, P., Rodgers, B., Murray, R., & Marmot, M. (1994). Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet, 344(8934), 1398-1402.
53. Jutras-Aswad, D., DiNieri, J. A., Harkany, T., & Hurd, Y. L. (2009). Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome. European Archives of Psychiatry and Clinical Neuroscience,259(7), 395-412.
54. Keller, A., Castellanos, F. X., Vaituzis, A. C., Jeffries, N. O., Giedd, J. N., & Rapoport, J. L. (2003). Progressive loss of cerebellar volume in childhood-onset schizophrenia. The American Journal of Psychiatry,160(1), 128-133.
55. Kerbeshian, J., & Burd, L. (1987). Are schizophreniform symptoms present in attenuated form in children with Tourette disorder and other developmental disorders. Canadian Journal of Psychiatry,32(2), 123-135.
56. Koenen, K. C., Moffitt, T. E., Roberts, A. L., Martin, L. T., Kubzansky, L., Harrington, H., et al. (2009). Childhood IQ and adult mental disorders: A test of the cognitive reserve hypothesis. The American Journal of Psychiatry,166(1), 50-57.
57. Koethe, D., Hoyer, C., & Leweke, F. M. (2009). The endocannabinoid system as a target for modelling psychosis. Psychopharmacology,206(4), 551-561.
58. Kolvin, I., Ounsted, C., Humphrey, M., & McNay, A. (1971). Studies in the childhood psychoses: II. The phenomenology of childhood psychoses. The British Journal of Psychiatry,118(545), 385-395.
59. Laurens, K. R., Hodgins, S., Maughan, B., Murray, R. M., Rutter, M. L., & Taylor, E. A. (2007). Community screening for psychotic-like experiences and other putative antecedents of schizophrenia in children aged 9-12 years.Schizophrenia Research,90(1-3), 130-146.
60. Laurens, K. R., West, S. A., Murray, R. M., & Hodgins, S. (2008). Psychotic-like experiences and other antecedents of schizophrenia in children aged 9-12 years: A comparison of ethnic and migrant groups in the United Kingdom. Psychological Medicine,38(8), 1103-1111.
61. Lewis, S. W., & Murray, R. M. (1987). Obstetric complications, neurodevelopmental deviance, and risk of schizophrenia. Journal of Psychiatric Research,21(4), 413-421.
62. Lucas, A. R., & Weiss, M. (1971). Methylphenidate hallucinosis. The Journal of the American Medical Association,217(8), 1079-1081.
63. Lukianowicz, N. (1969). Hallucinations in non-psychotic children. Psychiatria Clinica, 2(6), 321-337.
64. Maeda, K., Shirayama, Y., Nukina, S., Yoshioka, S., & Kawahara, R. (2003). Charles Bonnet syndrome with visual hallucinations of childhood experience: Successful treatment of 1 patient with risperidone. The Journal of Clinical Psychiatry,64(9), 1131-1132.
65. Maric, N., Kamer, T., Schneider Axmann, T., Dani, I., Jasovic Gasic, M., Paunovic, V. R., et al. (2003). Volumetric analysis of gray matter, white matter and cerebrospinal fluid space in schizophrenia. Srpski Arhiv za Celokupno Lekarstvo,131(1-2), 26-30.
66. Marquardt, R. K., Levitt, J. G., Blanton, R. E., Caplan, R., Asarnow, R., Siddarth, P., et al. (2005). Abnormal development of the anterior cingulate in childhood-onset schizophrenia: A preliminary quantitative MRI study. Psychiatry Research,138(3), 221-233.
67. McGee, R., Williams, S., & Poulton, R. (2000). Hallucinations in nonpsychotic children. Journal of the American Academy of Child and Adolescent Psychiatry,39(1), 12-13.
68. McGlashan, T. H., & Hoffman, R. E. (2000). Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Archives of General Psychiatry,57(7), 637-648.
69. McKenna, K., Gordon, C. T., Lenane, M., Kaysen, D., Fahey, K., & Rapoport, J. L. (1994). Looking for childhood-onset schizophrenia: The first 71 cases screened. Journal of the American Academy of Child and Adolescent Psychiatry, 33(5), 636-644.
70. Mewasingh, L. D., Kornreich, C., Christiaens, F., Christophe, C., & Dan, B. (2002). Pediatric phantom vision (Charles Bonnet) syndrome. Pediatric Neurology, 26(2), 143-145.
71. Meyers, E. F., & Charles, P. (1978). Prolonged adverse reactions to ketamine in children. Anesthesiology, 49(1), 39-40.
72. Ney, P. G. (1967). Psychosis in a child, associated with amphetamine administration. Canadian Medical Association Journal,97(17), 1026-1029.
73. Nicolson, R., Giedd, J. N., Lenane, M., Hamburger, S., Singaracharlu, S., Bedwell, J., et al. (1999). Clinical and neurobiological correlates of cytogenetic abnormalities in childhood-onset schizophrenia. The American Journal of Psychiatry,156(10), 1575-1579.
74. Ornoy, A. (2005). Growth and neurodevelopmental outcome of children born to mothers with pregestational and gestational diabetes. Pediatric Endocrinology Reviews,3(2), 104-113.
75. Page, P., Morgan, M., & Loh, L. (1972). Ketamine anaesthesia in paediatric procedures. Acta Anaesthesiologica Scandinavica,16(3), 155-160.
76. Pantelis, C., Velakoulis, D., McGorry, P. D., Wood, S. J., Suckling, J., Phillips, L. J., et al. (2003). Neuroanatomical abnormalities before and after onset of psychosis: A cross-sectional and longitudinal MRI comparison. Lancet,361(9354), 281-288.
77. Perel, A., & Davidson, J. T. (1976). Recurrent hallucinations following ketamine. Anaesthesia, 31(8), 1081-1083.
78. Polanczyk, G., Moffitt, T. E., Arseneault, L., Cannon, M., Ambler, A., Keefe, R. S., et al. (2010). Etiological and clinical features of childhood psychotic symptoms: Results from a birth cohort. Archives of General Psychiatry,67(4), 328-338.
79. Poulton, R., Caspi, A., Moffitt, T. E., Cannon, M., Murray, R., & Harrington, H. (2000). Children’s self-reported psychotic symptoms and adult schizophreniform disorder: A 15-year longitudinal study. Archives of General Psychiatry,57(11), 1053-1058.
80. Purves, D., & Lichtman, J. W. (1980). Elimination of synapses in the developing nervous system. Science,210(4466), 153-157.
81. Rapoport, J. L., Addington, A., & Frangou, S. (2005a). The neurodevelopmental model of schizophrenia: What can very early onset cases tell us?Current Psychiatry Reports,7(2), 81-82.
82. Rapoport, J. L., Addington, A. M., Frangou, S., & Psych, M. (2005b). The neurodevelopmental model of schizophrenia: Update 2005. Molecular Psychiatry,10(5), 434-449.
83. Rapoport, J. L., Giedd, J. N., Blumenthal, J., Hamburger, S., Jeffries, N., Fernandez, T., et al. (1999). Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study.Archives of General Psychiatry, 56(7), 649-654.
84. Rapoport, J. L., & Gogtay, N. (2008). Brain neuroplasticity in healthy, hyperactive and psychotic children: Insights from neuroimaging. Neuropsychopharmacology,33(1), 181-197.
85. Rashid, J., & Mitelman, S. (2007). Methylphenidate and somatic hallucinations. Journal of the American Academy of Child and Adolescent Psychiatry,46(8), 945-946.
86. Roberts, G. W., Colter, N., Lofthouse, R., Bogerts, B., Zech, M., & Crow, T. J. (1986). Gliosis in schizophrenia: A survey. Biological Psychiatry,21(11), 1043-1050.
87. Rothstein, A. (1981). Hallucinatory phenomena in childhood. A critique of the literature. Journal of the American Academy of Child Psychiatry,20(3), 623-635.
88. Rovner, B. W. (2006). The Charles Bonnet syndrome: A review of recent research. Current Opinion in Ophthalmology,17(3), 275-277.
89. Russell, A. T., Bott, L., & Sammons, C. (1989). The phenomenology of schizophrenia occurring in childhood. Journal of the American Academy of Child and Adolescent Psychiatry,28(3), 399-407.
90. Saha, S., Chant, D., Welham, J., & McGrath, J. (2005). A systematic review of the prevalence of schizophrenia. PLoS Medicine, 2(5), e141.
91. Schreier, H. A. (1999). Hallucinations in nonpsychotic children: More common than we think?Journal of the American Academy of Child and Adolescent Psychiatry,38(5), 623-625.
92. Schwartz, T. L., & Vahgei, L. (1998). Charles Bonnet syndrome in children. Journal of American Association for Pediatric Ophthalmology and Strabismus,2(5), 310-313.
93. Scott, J., Martin, G., Bor, W., Sawyer, M., Clark, J., & McGrath, J. (2009). The prevalence and correlates of hallucinations in Australian adolescents: Results from a national survey. Schizophrenia Research, 107(2-3), 179-185.
94. Smith, M. J., Thirthalli, J., Abdallah, A. B., Murray, R. M., & Cottler, L. B. (2009). Prevalence of psychotic symptoms in substance users: A comparison across substances. Comprehensive Psychiatry,50(3), 245-250.
95. Sosland, M. D., & Edelsohn, G. A. (2005). Hallucinations in children and adolescents. Current Psychiatry Reports,7(3), 180-188.
96. Spencer, E. K., & Campbell, M. (1994). Children with schizophrenia: Diagnosis, phenomenology, and pharmacotherapy. Schizophrenia Bulletin,20(4), 713-725.
97. Spom, A. L., Greenstein, D. K., Gogtay, N., Jeffries, N. O., Lenane, M., Gochman, P., et al. (2003). Progressive brain volume loss during adolescence in childhood-onset schizophrenia. The American Journal of Psychiatry,160(12), 2181-2189.
98. St Clair, D., Xu, M., Wang, P., Yu, Y., Fang, Y., Zhang, F., et al. (2005). Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. The Journal of the American Medical Association,294(5), 557-562.
99. Thompson, P. M., Hayashi, K. M., Sowell, E. R., Gogtay, N., Giedd, J. N., Rapoport, J. L., et al. (2004). Mapping cortical change in Alzheimer’s disease, brain development, and schizophrenia. NeuroImage,23(Suppl 1), S2-S18.
100. Thompson, P. M., Vidal, C., Giedd, J. N., Gochman, P., Blumenthal, J., Nicolson, R., et al. (2001). Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proceedings of the National Academy of Sciences of the United States of America,98(20), 11650-11655.
101. Tillman, R., Geller, B., Klages, T., Corrigan, M., Bolhofner, K., & Zimerman, B. (2008). Psychotic phenomena in 257 young children and adolescents with bipolar I disorder: Delusions and hallucinations (benign and pathological).Bipolar Disorders,10(1), 45-55.
102. Toda, M., & Abi-Dargham, A. (2007). Dopamine hypothesis of schizophrenia: Making sense of it all. Current Psychiatry Reports, 9(4), 329-336.
103. Treston, G., Bell, A., Cardwell, R., Fincher, G., Chand, D., & Cashion, G. (2009). What is the nature of the emergence phenomenon when using intravenous or intramuscular ketamine for paediatric procedural sedation?Emergency Medicine Australasia,21(4), 315-322.
104. Tuerlings, J. H., Wijnen, H., Boerman, R., & Verwey, B. (2009). Music as an uninvited guest: The auditive variant of the Charles Bonnet syndrome. Tijdschrift voor Psychiatrie,51(11), 853-858.
105. Ulloa, R. E., Birmaher, B., Axelson, D., Williamson, D. E., Brent, D. A., Ryan, N. D., et al. (2000). Psychosis in a pediatric mood and anxiety disorders clinic: Phenomenology and correlates. Journal of the American Academy of Child and Adolescent Psychiatry,39(3), 337-345.
106. van Os, J., Hanssen, M., Bijl, R. V., & Ravelli, A. (2000). Strauss (1969) revisited: A psychosis continuum in the general population?Schizophrenia Research,45(1-2), 11-20.
107. van Os, J., Hanssen, M., Bijl, R. V., & Vollebergh, W. (2001). Prevalence of psychotic disorder and community level of psychotic symptoms: An urban-rural comparison. Archives of General Psychiatry, 58(7), 663-668.
108. van Os, J., Linscott, R. J., Myin-Germeys, I., Delespaul, P., & Krabbendam, L. (2009). A systematic review and meta-analysis of the psychosis continuum: Evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychological Medicine, 39(2), 179-195.
109. Visanji, N. P., Gomez-Ramirez, J., Johnston, T. H., Pires, D., Voon, V., Brotchie, J. M., et al. (2006). Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson’s disease.Movement Disorders,21(11), 1879-1891.
110. Weinberger, D. R. (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry, 44(7), 660-669.
111. Werry, J. S., McClellan, J. M., & Chard, L. (1991). Childhood and adolescent schizophrenic, bipolar, and schizoaffective disorders: A clinical and outcome study. Journal of the American Academy of Child and Adolescent Psychiatry, 30(3), 457-465.
112. Wiles, N. J., Zammit, S., Bebbington, P., Singleton, N., Meltzer, H., & Lewis, G. (2006). Selfreported psychotic symptoms in the general population: Results from the longitudinal study of the British National Psychiatric Morbidity Survey. The British Journal of Psychiatry, 188, 519-526.
113. Wilking, V. N., & Paoli, C. (1966). The hallucinatory experience: an attempt at a psychodynamic classification and reconsideration of its diagnostic significance, Journal of the American Academy of Child Psychiatry,5(3), 431-440.
114. Woodberry, K. A., Giuliano, A. J., & Seidman, L. J. (2008). Premorbid IQ in schizophrenia: A meta-analytic review. The American Journal of Psychiatry, 165(5), 579-587.
115. Woods, B. T. (1998). Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. The American Journal of Psychiatry,155(12), 1661-1670.
116. Yoshizumi, T., Murase, S., Honjo, S., Kaneko, H., & Murakami, T. (2004). Hallucinatory experiences in a community sample of Japanese children. Journal of the American Academy of Child and Adolescent Psychiatry,43(8), 1030-1036.
117. Zammit, S., Odd, D., Horwood, J., Thompson, A., Thomas, K., Menezes, P., et al. (2009). Investigating whether adverse prenatal and perinatal events are associated with non-clinical psychotic symptoms at age 12 years in the ALSPAC birth cohort. Psychological Medicine, 39(9), 1457-1467.